Compare TK & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TK | BLFS |
|---|---|---|
| Founded | 1973 | 1987 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 937.1M | 923.5M |
| IPO Year | 1995 | 2013 |
| Metric | TK | BLFS |
|---|---|---|
| Price | $12.90 | $19.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | ★ 501.7K | 368.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 15.71% | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | N/A | $19.73 |
| Revenue Next Year | N/A | $17.82 |
| P/E Ratio | $13.43 | ★ N/A |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $5.83 | $17.86 |
| 52 Week High | $13.76 | $29.57 |
| Indicator | TK | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 64.02 | 43.83 |
| Support Level | $8.99 | $17.86 |
| Resistance Level | $13.76 | $20.47 |
| Average True Range (ATR) | 0.47 | 0.78 |
| MACD | 0.08 | 0.16 |
| Stochastic Oscillator | 98.31 | 51.16 |
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.